Validation of lipo-LOX activity

AV Alessandro De Vita
CL Chiara Liverani
RM Roberto Molinaro
JM Jonathan O. Martinez
KH Kelly A. Hartman
CS Chiara Spadazzi
GM Giacomo Miserocchi
FT Francesca Taraballi
ME Michael Evangelopoulos
FP Federica Pieri
AB Alberto Bongiovanni
LM Laura Mercatali
ET Ennio Tasciotti
TI Toni Ibrahim
request Request a Protocol
ask Ask a question
Favorite

To confirm the activity of LOX antibody after the liposome functionalization, secreted LOX protein was quantified in the cells culture medium at different time points. Briefly, MDA-MB-231 cultured both in standard monolayer and tridimensional culture were exposed to Lipo, EPI, Lipo-EPI, and Lipo-EPI-LOX at the concentration of the human plasma peak as specified in the drug testing section. Culture medium was collected at 6, 24, and 48 h respectively. The medium was centrifuged at 15,000 rpm for 20 min at 4 °C and the pellet was discarded to eliminate cell debris. The protein contents were determined using a BCA protein assay kit (Pierce BCA Protein Assay Kit, Thermo Scientific). An equal amount of protein from each sample was separated on Criterion Precast Gel Tris–HCl (Biorad, Hercules, CA, USA) and transferred to polyvinylidene fluoride membranes (Millipore Corporation)44. The membranes were blocked for 2 h with a solution containing 5% fat-free milk PBS with 0.1% Tween 20 (Sigma-Aldrich) at room temperature and incubated overnight at 4 °C with anti-LOX antibody (1:1000 ab31238, Abcam, Cambridge, UK). The membranes were then washed and incubated for 1 h at room temperature with horseradish peroxidase-conjugated secondary antibody following the protocol previously reported45.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A